A detailed history of Cwm, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Cwm, LLC holds 9,319 shares of ADPT stock, worth $43,706. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,319
Previous 6,441 44.68%
Holding current value
$43,706
Previous $23,000 108.7%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$3.37 - $5.12 $9,698 - $14,735
2,878 Added 44.68%
9,319 $48,000
Q2 2024

Jul 09, 2024

BUY
$2.34 - $3.96 $6,542 - $11,072
2,796 Added 76.71%
6,441 $23,000
Q1 2024

Apr 05, 2024

BUY
$2.88 - $4.8 $1,647 - $2,745
572 Added 18.61%
3,645 $12,000
Q4 2023

Feb 01, 2024

SELL
$3.46 - $5.33 $9,196 - $14,167
-2,658 Reduced 46.38%
3,073 $15,000
Q3 2023

Oct 11, 2023

SELL
$5.07 - $8.44 $822,343 - $1.37 Million
-162,198 Reduced 96.59%
5,731 $31,000
Q2 2023

Aug 03, 2023

SELL
$6.19 - $8.78 $43,466 - $61,653
-7,022 Reduced 4.01%
167,929 $1.13 Million
Q1 2023

Apr 28, 2023

SELL
$7.8 - $10.11 $70,340 - $91,171
-9,018 Reduced 4.9%
174,951 $1.55 Million
Q4 2022

Feb 01, 2023

SELL
$6.26 - $9.34 $242,268 - $361,467
-38,701 Reduced 17.38%
183,969 $1.41 Million
Q3 2022

Oct 27, 2022

SELL
$6.5 - $12.67 $76,914 - $149,924
-11,833 Reduced 5.05%
222,670 $1.59 Million
Q2 2022

Jul 28, 2022

SELL
$6.4 - $14.73 $221,926 - $510,777
-34,676 Reduced 12.88%
234,503 $1.9 Million
Q1 2022

Apr 21, 2022

SELL
$10.12 - $28.9 $351,103 - $1 Million
-34,694 Reduced 11.42%
269,179 $3.74 Million
Q4 2021

Jan 31, 2022

BUY
$25.17 - $36.85 $5.03 Million - $7.37 Million
199,932 Added 192.35%
303,873 $8.53 Million
Q1 2021

Sep 15, 2021

BUY
$37.26 - $67.74 $186,262 - $338,632
4,999 Added 5.05%
103,941 $4.25 Million
Q1 2021

Apr 27, 2021

SELL
$37.26 - $67.74 $186,262 - $338,632
-4,999 Reduced 4.81%
98,942 $3.98 Million
Q4 2020

Sep 15, 2021

BUY
$45.01 - $65.47 $2 Million - $2.92 Million
44,535 Added 74.97%
103,941 $4.25 Million
Q4 2020

Jan 27, 2021

SELL
$45.01 - $65.47 $2 Million - $2.92 Million
-44,535 Reduced 42.85%
59,406 $3.51 Million
Q3 2020

Sep 15, 2021

BUY
$35.79 - $48.81 $1.68 Million - $2.3 Million
47,037 Added 82.66%
103,941 $4.25 Million
Q3 2020

Oct 19, 2020

SELL
$35.79 - $48.81 $1.68 Million - $2.3 Million
-47,037 Reduced 45.25%
56,904 $2.77 Million
Q2 2020

Sep 15, 2021

BUY
$24.95 - $48.38 $2.59 Million - $5.03 Million
103,941 New
103,941 $4.25 Million
Q2 2020

Jul 22, 2020

SELL
$24.95 - $48.38 $2.59 Million - $5.03 Million
-103,941 Closed
0 $0
Q1 2020

Sep 15, 2021

BUY
$16.96 - $34.16 $1.76 Million - $3.55 Million
103,941 New
103,941 $4.25 Million
Q1 2020

Apr 28, 2020

SELL
$16.96 - $34.16 $1.76 Million - $3.55 Million
-103,941 Closed
0 $0
Q4 2019

Sep 14, 2021

BUY
$24.56 - $32.8 $2.55 Million - $3.41 Million
103,941 New
103,941 $4.25 Million
Q4 2019

Jan 27, 2020

SELL
$24.56 - $32.8 $2.55 Million - $3.41 Million
-103,941 Closed
0 $0
Q3 2019

Sep 14, 2021

BUY
$30.31 - $53.51 $3.15 Million - $5.56 Million
103,941 New
103,941 $4.25 Million
Q3 2019

Oct 22, 2019

SELL
$30.31 - $53.51 $3.15 Million - $5.56 Million
-103,941 Closed
0 $0
Q2 2019

Sep 14, 2021

BUY
$40.3 - $48.3 $4.19 Million - $5.02 Million
103,941 New
103,941 $4.25 Million
Q2 2019

Jul 31, 2019

SELL
$40.3 - $48.3 $4.19 Million - $5.02 Million
-103,941 Closed
0 $0
Q1 2019

Sep 02, 2021

BUY
N/A
103,941 New
103,941 $0

Others Institutions Holding ADPT

About Adaptive Biotechnologies Corp


  • Ticker ADPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,872,992
  • Market Cap $670M
  • Description
  • Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...
More about ADPT
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.